A 91.18% collapse in Sionna Therapeutics’ share price has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The firm is currently reviewing whether company leadership misled investors regarding the clinical efficacy of its lead nucleotide binding domain 1 stabilizer programs.
Following the sudden resignation of Chief Executive Officer John Marotta, the Pomerantz Law Firm has initiated an investigation into Azenta, Inc. to determine if the company or its leadership engaged in securities fraud or unlawful business practices, potentially impacting shareholder value and corporate governance standards.
A series of regulatory challenges and internal billing disputes has triggered a formal investigation by Pomerantz LLP into Hims & Hers Health. The firm is examining potential securities fraud and unlawful business practices following allegations regarding the company's handling of sensitive patient data and its subscription billing policies.
A 45% collapse in share price following disappointing second-quarter results has triggered a formal investigation into AirSculpt Technologies. New York-based Pomerantz LLP is currently examining whether the company or its leadership engaged in securities fraud or unlawful business practices, potentially opening the door for a class-action lawsuit.
Investors who purchased Pentair plc securities between April 28 and July 14, 2026, face an October 2 deadline to seek appointment as lead plaintiff in a pending class action lawsuit. The litigation alleges that the company misled shareholders regarding significant inventory destocking within its pool channel.
With over 5.7 million annual visits, Midtown Village in Tuscaloosa has become the latest acquisition for JLL Income Property Trust. The Chicago-based REIT finalized the purchase of the 345,000-square-foot open-air shopping center for approximately $94 million, citing the property's prime location and stable tenant base as key drivers.
Pomerantz LLP has initiated a class action lawsuit against Fractyl Health, Inc. and its senior officers, alleging the company misled shareholders regarding the efficacy of its Revita DMR System. The litigation follows a sharp decline in share price triggered by disappointing clinical data released in early 2026.
Investors have launched a class action lawsuit against Aardvark Therapeutics, alleging the biopharmaceutical company misled shareholders about the safety and commercial viability of its lead drug candidate, ARD-101. The complaint, filed in the Southern District of California, targets disclosures made during the company’s February 2025 initial public offering.
A new class action lawsuit filed in the Northern District of Illinois alleges that Wix.com misled shareholders regarding the competitiveness and financial burden of its artificial intelligence initiatives. The complaint claims the company overstated the capabilities of its AI products while masking escalating development costs that pressured its stock price.
Investors who purchased EquipmentShare stock face a September 21 deadline to seek lead plaintiff status in a newly filed class action lawsuit. The litigation targets the company and its leadership following allegations of undisclosed related-party transactions and deceptive business practices that surfaced earlier this year.
Investors who suffered losses in GPGI, Inc. have until September 14, 2026, to seek appointment as lead plaintiff in a class action lawsuit filed by Pomerantz LLP. The litigation targets the company and its leadership over allegations of securities fraud and deceptive business practices during the past year.
A class action lawsuit filed in the U.S. District Court for the District of Massachusetts alleges that Insulet Corporation misled shareholders regarding the safety and manufacturing integrity of its Omnipod insulin delivery systems. The litigation seeks to recover damages for investors who purchased stock during a period of recurring device corrections.
Investors in Hub Group have until August 28, 2026, to seek lead plaintiff status in a class action lawsuit following the company's disclosure of material accounting misstatements. The litigation targets alleged securities fraud stemming from systemic failures in financial reporting that triggered significant drops in the firm's share price.
Investors who purchased Hertz Global Holdings stock are facing a pivotal deadline as a class action lawsuit moves forward following the company's abrupt financial disclosure. The litigation centers on allegations of securities fraud, specifically questioning whether the firm misled shareholders regarding liquidity and its exposure to a softening used car market.
Investors who suffered losses in Regeneron Pharmaceuticals are facing a September 14, 2026, deadline to seek appointment as lead plaintiff in a pending class action lawsuit. The litigation centers on allegations of securities fraud linked to the company’s disclosures regarding its Phase III Fianlimab-Libtayo clinical trial.
Investors who suffered losses in Photronics, Inc. have until September 4, 2026, to seek appointment as lead plaintiff in a class action lawsuit. The litigation targets the company and its leadership, alleging securities fraud following a sharp decline in financial performance and a subsequent 36.4% drop in share value.
Pomerantz LLP has initiated a class action lawsuit against Datavault AI Inc. and its top executives, alleging the company misled shareholders through inflated partnership claims and by concealing the troubled pasts of key figures. The legal action follows a sharp decline in share price triggered by a critical report.
Pomerantz LLP has filed a class action lawsuit against Intuit Inc. and several top executives in the U.S. District Court for the Northern District of California. The litigation claims the company misled investors regarding its competitive standing and revenue growth targets during the 2026 fiscal year.
A federal class action lawsuit has been filed against Pentwater Capital Management and its CEO Matthew Halbower, alleging the firm orchestrated a massive market manipulation scheme involving Avis Budget Group. The litigation seeks to recover damages for investors who traded Avis securities during a period of extreme, artificial stock volatility.
A class action lawsuit filed by Pomerantz LLP alleges that Cogent Communications Holdings misled shareholders regarding its wavelength business operations and financial health. Investors seeking to serve as lead plaintiff in the case against the telecommunications company have until September 21, 2026, to file their petitions with the court.
Investors who suffered losses in Primoris Services Corporation are being urged to join a newly filed class action lawsuit. Pomerantz LLP initiated the litigation, alleging that the firm and its executives engaged in securities fraud, with a court deadline of September 21, 2026, for those seeking lead plaintiff status.
Harold Ford Jr. joins Charlotte-based Truist Financial Corporation on August 31, stepping into the role of vice chair for the firm’s wholesale banking division. Reporting to Chief Wholesale Banking Officer Kristin Lesher, he will focus on expanding client relationships and driving business growth across the company’s corporate and institutional sectors.
A consortium of Northeast utilities has tapped Reston-based ICF to continue managing a massive portfolio of residential energy efficiency and electrification programs. The $20 million recompete contract, awarded in the second quarter of 2026, focuses on scaling building performance standards to drive down customer costs and bolster regional grid stability.
Investors and industry leaders will convene in New York City on September 15, 2026, as Harmonic hosts an exclusive look at its shift toward a pure-play broadband technology model. The two-hour event aims to clarify the company's long-term growth strategy and its role in the evolving infrastructure landscape.
Shareholders of EastGroup Properties are set to receive a larger quarterly payout after the company's Board of Directors approved a 12.9 percent dividend hike. The increase brings the distribution to $1.75 per share, marking the latest milestone in a 34-year streak of maintaining or raising dividend payments.
Fremont-based semiconductor equipment manufacturer Lam Research Corporation is boosting its quarterly dividend by 27 percent, raising the payout from $0.26 to $0.33 per share. This move underscores the company’s current financial standing as it continues to supply critical wafer fabrication technology to global chipmakers.
As the single-dose detergent market climbs toward a projected $6.3 billion valuation by 2035, Bowling Green-based SmartSolve is targeting the industry’s reliance on polyvinyl alcohol. The company has introduced PureNil 0, a bio-based, water-soluble packaging material designed to eliminate the microplastic runoff associated with traditional laundry and dishwasher pods.
Sydney-based oncology firm Kazia Therapeutics has initiated a tranched registered public offering of American Depositary Shares and accompanying warrants. The company aims to leverage the capital to accelerate clinical development of its lead drug candidate, paxalisib, across multiple breast cancer indications and other oncology research programs.
IM Cannabis Corp. has officially implemented a 30-for-1 reverse stock split, with the company's common shares beginning trade on the Nasdaq Capital Market under the new consolidated structure today. The move reduces the total outstanding share count from approximately 18.57 million to roughly 618,899 shares, excluding fractional adjustments.
Virginia’s water and wastewater systems remain stuck in a cycle of neglect, earning stagnant grades of C+ and D+ respectively in the 2026 American Society of Civil Engineers report. The lack of movement over the past four years signals a deepening crisis for the state’s aging utility infrastructure.
